Emicizumab-kxwh Subcutaneous and EndaCof-PD
Determining the interaction of Emicizumab-kxwh Subcutaneous and EndaCof-PD and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: brompheniramine / dextromethorphan / guaifenesin / phenylephrine
Brand name: AccuHist PDX Syrup, Allanhist PDX Syrup, Bromhist-PDX, EndaCof-PD, Uni-Hist PDX Syrup
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Endal CD Syrup
- Emicizumab-kxwh Subcutaneous-Endocet
- Emicizumab-kxwh Subcutaneous-Endocet 10/325
- Emicizumab-kxwh Subcutaneous-Endocet 2.5/325
- Emicizumab-kxwh Subcutaneous-Endocet 5/325
- Emicizumab-kxwh Subcutaneous-Endocet 7.5/325
- EndaCof-PD-Emla
- EndaCof-PD-Emla Topical
- EndaCof-PD-Emo-Cort Scalp Solution Topical application
- EndaCof-PD-Emo-Cort Topical application
- EndaCof-PD-Emoquette
- EndaCof-PD-Empagliflozin